A short course of antibiotic treatment is effective in preventing death from experimental inhalational anthrax after discontinuing antibiotics

Area of Science:

• Infectious Diseases
• Microbiology
• Pharmacology

Background:

• Inhalational anthrax treatment typically involves prolonged antibiotic therapy or a combination of antibiotics and vaccination.
• Concerns exist regarding disease recurrence from germinating spores after antibiotic cessation.
• The optimal duration for treating established inhalational anthrax remains debated.

Purpose of the Study:

• To evaluate the efficacy of a short antibiotic treatment course versus prolonged prophylaxis for inhalational anthrax.
• To determine if a limited treatment duration can prevent Bacillus anthracis spore germination post-antibiotic discontinuation.
• To compare survival rates in rhesus macaques receiving different ciprofloxacin regimens.

Main Methods:

• Two groups of 10 rhesus macaques were exposed to Bacillus anthracis spores.
• Group 1 received ciprofloxacin prophylaxis early post-exposure.
• Group 2 received ciprofloxacin treatment initiated upon bacteremia, continuing for 10 days.

Main Results:

• In the prophylaxis group (Group 1), 80% of animals died after antibiotic discontinuation.
• In the treatment group (Group 2), 100% of surviving animals remained disease-free after completing 10 days of therapy.
• While 3 deaths occurred during treatment in Group 2, overall survival post-therapy was significantly higher.

Conclusions:

• Prolonged antibiotic courses for inhalational anthrax prophylaxis may not be essential.
• A targeted treatment approach can effectively manage established inhalational anthrax.
• Short-term antibiotic therapy can prevent late-onset disease from dormant Bacillus anthracis spores.